DANNY BRONSHTEIN: Open Payments
NPI 1417489188 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,866 in 70 payments from 17 companies in 2025. Trend: 2023 $546 · 2024 $1,035 · 2025 $1,866
Food & beverage: $1,771Education: $95
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 11 | $323 |
| Incyte Corporation | 13 | $322 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $185 |
| Novartis Pharmaceuticals Corporation | 5 | $149 |
| Janssen Biotech, Inc. | 3 | $147 |
| ABBVIE INC. | 5 | $146 |
| Amgen Inc. | 5 | $120 |
| Verrica Pharmaceuticals Inc. | 3 | $69 |
| Botanix SB Inc | 2 | $61 |
| Lilly USA, LLC | 3 | $59 |
Products named: Zoryve, OPZELURA, TREMFYA, SKYRIZI, OTEZLA, COSENTYX, YCANTH, SOFDRA.
Industry payments across NY — which companies pay providers there.
